RxDoctor Payments Data

Stephanie Williams, DO

Family Medicine · Seymour, INNPI 1679035430

Payments from drug & device makers

$239in general payments, 2019–2025

Across 14 payments — averaging $17.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$60
  • AbbVie$52
  • Boehringer Ingelheim$36
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$18
  • Novo Nordisk$15
  • Idorsia Pharmaceuticals US Inc$15
  • plus $42 from 3 others

What the payments were for

  • Food & beverage$239100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$239 in reported general payments places this provider in the 35th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$3,409
Medicare patients
70
Services billed
194

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide48$54,006
TrulicityDulaglutide51$53,292
Trelegy ElliptaFluticasone/Umeclidin/Vilanter66$51,678
EliquisApixaban57$51,036
OzempicSemaglutide46$45,094
FarxigaDapagliflozin Propanediol36$44,450
JardianceEmpagliflozin25$26,608
ProliaDenosumab12$21,285
RybelsusSemaglutide12$19,911
XareltoRivaroxaban14$16,868
MyrbetriqMirabegron18$9,769
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$8,073
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$2,956
Albuterol Sulfate HfaAlbuterol Sulfate78$2,547
Atorvastatin Calcium308$1,802

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$60$107,29899 claims
Novo NordiskOzempic, Rybelsus$15$65,00658 claims
Boehringer IngelheimJardiance$36$26,60825 claims
AmgenProlia$14$21,28512 claims
AbbVieSynthroid$52$1,06714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Seymour

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →